Yucca Health

About Yucca Health

Yucca Health entered the GLP-1 telehealth market in 2025 and has quickly built an impressive volume of patient feedback, with over 970 reviews on Trustpilot and a strong 4.6-star rating. The platform offers compounded semaglutide and compounded tirzepatide at prices ranging from $146 to $258 per month, placing it among the more affordable options in the compounded medication space. For a relatively young company, the pace at which Yucca Health has accumulated positive reviews is noteworthy.

The Trustpilot profile tells an encouraging story about patient satisfaction, with the 4.6-star rating across nearly 1,000 reviews suggesting that the majority of customers have had positive experiences with the platform. This volume of feedback provides a more statistically meaningful picture than many competitors, and it indicates that Yucca Health is doing something right when it comes to basic service delivery and medication fulfillment. However, it is worth noting that the company does not yet have a Better Business Bureau listing, which limits one avenue of independent oversight.

One area where Yucca Health falls short is cost transparency. Our research flagged this as a notable weakness — prospective patients may find it difficult to determine exact pricing before committing to the platform. In a market where consumers are increasingly savvy about comparing costs across providers, a lack of upfront pricing clarity can erode trust and create frustration during the sign-up process. Providers that clearly display their pricing structure tend to perform better in our trust assessments.

Clinically, Yucca Health follows the common telehealth model of providing prescriptions without extensive wraparound support. The platform does not include lab testing or dietitian access as part of its standard program. While this keeps costs low, it does mean patients are largely on their own when it comes to monitoring health markers and implementing the dietary changes that maximize GLP-1 medication effectiveness. For patients who want a more comprehensive approach, this may be a limiting factor.

Overall, Yucca Health presents an interesting value proposition: affordable compounded GLP-1 medications backed by a high volume of positive patient reviews, tempered by limited clinical support and some transparency concerns. The strong Trustpilot performance distinguishes it from many competitors in the budget tier, but the lack of lab work, dietary support, and BBB accreditation keeps it from reaching the upper echelon of our ratings. It is a solid option for cost-conscious patients who are comfortable with a streamlined, medication-focused approach.

Yucca Health GLP-1 Medications

At a Glance